MedTrace Logo

The ABEL Feasibility Study (Adherence, Better Health, Exercise and Life Satisfaction)

NCT05792657 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-03-31

No results posted yet for this study

Summary

The ambition of the ABEL feasibility study is to test new "green prescription" follow-up models that can get more women with obesity, regularly active, with improved health and physical fitness. The project will evaluate the effect on exercise behavior, total physical activity level and mental and physical health outcomes by four different follow-up models by an exercise professional: HIGH-dosage in-person exercise coaching (four session monthly), MEDIUM- dosage in-person exercise coaching (two sessions monthly) LOW-dosage in-person exercise coaching (one session monthly). The main aim of this study is to evaluate which of these follow-up models is most effective on improving women's exercise adherence, total physical activity level, physical fitness, and mental and physical health. This will be weighed against the cost of each of the follow-up models, in order to identify the best model from a socioeconomic cost-effectiveness perspective. Moreover, the study will identify potential barriers among patients, General Practitioners and exercise professionals that prevents optimal outcome from the current green prescription model.

Conditions

Interventions

BEHAVIORAL

High dosage in-person exercise coaching

High dosage (one hour each week) of in-person exercise coaching by an exercise professional.

BEHAVIORAL

Medium dosage in-person exercise coaching.

Medium dosage (one hour every other week) of in-person exercise coaching by an exercise professional.

BEHAVIORAL

Low dosage in-person exercise coaching

Low dosage (one hour every month) of in-person exercise coaching by an exercise professional

Sponsors & Collaborators

  • Kristiania University College

    collaborator OTHER

  • ABEL Technologies

    collaborator UNKNOWN

  • Norges idrettshøgskole

    lead OTHER

Principal Investigators

  • Tron Krosshaug, PhD · Norwegian School of Sport Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-26
Primary Completion
2023-06-26
Completion
2023-06-26

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05792657 on ClinicalTrials.gov